Perioperative Flare in RA: Characterization of Clinical and Biological Features
NCT ID: NCT02111057
Last Updated: 2019-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
162 participants
OBSERVATIONAL
2013-10-16
2017-05-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Through this study we aim to describe rates, characteristics, and risk factors of RA flare within 6 weeks of total hip arthroplasty (THA) and total knee arthroplasty (TKA)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Discovering the Antecedents of Rheumatoid Arthritis Flare
NCT02051114
Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)
NCT02382783
Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
NCT04488497
Study of Some Risk Factors for Developing RA
NCT03624179
Health Outcomes in Rheumatoid Arthritis
NCT00346411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Perioperative RA
Patients with Rheumatoid Arthritis undergoing a primary or secondary total hip replacement, between the ages of 18 and 90.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with Rheumatoid Arthritis undergoing total joint replacement surgery
3. Satisfy American College of Rheumatology(ACR)/European League Against Rheumatism(EULAR) 2010 classification criteria and/or the 1987 RA criteria (see below) and be diagnosed with RA
4. For control subjects: Have OA(Osteoarthritis), SLE(Systemic lupus erythematosus) or other inflammatory arthritis.
Exclusion Criteria
2. Diagnosis of or crystalline arthropathy.
3. Unable to understand or read English.
4. Unable to follow the study protocol in a reliable manner.
5. Age \< 18 or \>75.
EXPLANATION OF CRITERIA:
Rheumatoid arthritis 1987 criteria:
1. morning stiffness in and around joints lasting at least 1 hour before maximal improvement;
2. soft tissue swelling (arthritis) of 3 or more joint areas observed by a physician;
3. swelling (arthritis) of the proximal interphalangeal, metacarpophalangeal, or wrist joints;
4. symmetric swelling (arthritis);
5. rheumatoid nodules;
6. the presence of rheumatoid factor; and
7. radiographic erosions and/or periarticular osteopenia in hand and/or wrist joints.
* Criteria 1 through 4 must have been present for at least 6 weeks. Rheumatoid arthritis is defined by the presence of 4 or more criteria, and no further qualifications (classic, definite, or probable) or list of exclusions are required.
ACR/EULAR 2010 criteria for the classification of RA:
Table 3. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis
Target population (Who should be tested?): Patients who
1. have at least 1 joint with definite clinical synovitis (swelling)\*
2. with the synovitis not better explained by another disease
Classification criteria for RA (score-based algorithm: add score of categories A-D;
a score of ≥6/10 is needed for classification of a patient as having definite RA
Score
A. Joint involvement
1 large joint 0
2-10 large joints 1
1-3 small joints (with or without involvement of large joints) 2
4-10 small joints (with or without involvement of large joints) 3
\>10 joints (at least 1 small joint) 5
B. Serology (at least 1 test result is needed for classification)
Negative RF and negative ACPA 0
Low-positive RF or low-positive ACPA 2
High-positive RF or high-positive ACPA 3
C. Acute-phase reactants (at least 1 test result is needed for classification)
Normal CRP and normal ESR 0
Abnormal CRP or abnormal ESR 1
D. Duration of symptoms
\< 6 weeks 0
* 6 weeks 1
* The criteria are aimed at classification of newly presenting patients. In addition, patients with erosive disease typical of rheumatoid arthritis (RA) with a history compatible with prior fulfillment of the 2010 criteria should be classified as having RA. Patients with longstanding disease, including those whose disease is inactive (with or without treatment) who, based on retrospectively available data, have previously fulfilled the 2010 criteria should be classified as having RA.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital for Special Surgery, New York
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital for Special Surgery
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Hospital for Special Surgery
Principal Investigator, Susan Goodman MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.